Clinical Trial Update: A Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With SCD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating haploidentical T-depleted stem cell transplantation in patients with sickle cell disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hbs Disease
• Hemoglobin Disease
• Sickle Cell Disease
• Sickle Cell Disorders
• Sickling Disorder Due to Hemoglobin

Snippet

Sponsor: University of Regensburg | Conditions: HbS Disease, Hemoglobin S Disease | Phase 2 | Status: RECRUITING